
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results And Provides Business Update
(MENAFN- GlobeNewsWire - Nasdaq) Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update Successful strategic shift towards a focus on inflammatory and fibrotic diseases, in particular on kidney disease …